Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer

Although multigene panel testing is increasingly common in patients with cancer, the relationship between its use among breast cancer patients with non‐BRCA mutations or variants of uncertain significance (VUS) and disease management decisions has not been well described. This study evaluated the ra...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Elsayegh, Nisreen, Webster, Rachel D., Gutierrez Barrera, Angelica M., Lin, Heather, Kuerer, Henry M., Litton, Jennifer K., Bedrosian, Isabelle, Arun, Banu K.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Cancer Prevention
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6010764/
https://ncbi.nlm.nih.gov/pubmed/29733510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1519
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items